Investor Presentation
152
Investor presentation First six months of 2022
Reaching more patients will increase the plastic footprint, a
challenge Novo Nordisk has started to address
Growing volumes impact Novo Nordisk's plastic footprint
ILLUSTRATIVE
.
•
Change to sustainable plastic
Engage with suppliers to pursue shift to
sustainable plastic
• Drive innovation via partnerships to e.g. re-
purpose medical waste
Reduce plastic consumption
Drive portfolio decisions towards lower plastic
consumption
Drive switch towards durable devices in relevant
markets
12,000 tonnes
of plastic in
production of
devices
2021
2030
•
Plastic volume
1 More information on the pilot called "ReturpenTM" can be found here: Returpen.dk
•
Avoid plastic waste on landfill
Take-back¹ pilot in Denmark with partners leading to
>20% device return
Take-back expansion to UK, Brazil and France with
ambition to establish industry solution for scaling
Novo NordiskⓇView entire presentation